Session Information
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer in Singapore
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
All times listed are in Singapore time (GMT+8)
PL - Plenary
PS - Presidential Symposium
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
IS - Industry Symposium
JICC - Joint IASLC-CAALC-CSCO Session
January 28 Thu
Jan 28 Friday
January 29 Fri
Jan 29 Saturday
January 30 Sat
Jan 30 Sunday
January 31 Sun
Jan 31
-
+
P89 - Targeted Therapy - Clinically Focused - Translational
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Targeted Therapy - Clinically Focused
-
+
P89.01 - Clinical and Genomic Features of EGFR-KDD/EGFR Rearrangements of Chinese Lung Cancer Patients
00:00 - 00:00 | Presenter: Chengzhi Zhou
- Abstract
Loading... -
+
P89.02 - The Effect of Racial Diversity on the Landscape of Targetable Genomic Alterations in Patients with Lung Adenocarcinomas
00:00 - 00:00 | Presenter: Yanyan Lou
- Abstract
Loading... -
+
P89.03 - Demonstrating VALUE of Liquid Biopsy for Lung Cancer in a Public Healthcare System
00:00 - 00:00 | Presenter: Desiree Hao
- Abstract
Loading... -
+
P89.04 - Real-World First Line Targeted Therapy Duration Following ctDNA Testing in Advanced Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Chuck H. Hensel
- Abstract
Loading... -
+
P89.05 - Management of Patients with EGFR and ALK-Mutated Advanced Non-Small Cell Lung Cancer Post-TKI Therapy – A Real-World Survival Analysis
00:00 - 00:00 | Presenter: Kathleen Claire Kerrigan
- Abstract
Loading... -
+
P89.06 - Prospective Concordance Study of a Multi-Gene PCR Assay and NGS for the Detection of Targetable Gene Alterations in Lung Cancer
00:00 - 00:00 | Presenter: Shingo Matsumoto
- Abstract
Loading... -
+
P89.07 - A Large-Scale Survey of IDH1/2 Mutation in Chinese Patients With NSCLC
00:00 - 00:00 | Presenter: Meizi Jin
- Abstract
Loading... -
+
P89.08 - Real-World Impact of Plasma Cell-Free DNA Next-Generation Sequencing to Detect Actionable Genomic Alterations in Advanced NSCLC
00:00 - 00:00 | Presenter: Beung-Chul Ahn
- Abstract
Loading... -
+
P89.09 - The Landscape of Kinase Domain Duplication (KDD) in Chinese Lung Cancer Patients
00:00 - 00:00 | Presenter: Pingli Wang
- Abstract
Loading... -
+
P89.10 - Genomic Alteration Features and Targeted Therapy Opportunities of Primary Thoracic Sarcoma Patients
00:00 - 00:00 | Presenter: Lixia Ju
- Abstract
Loading... -
+
P89.11 - Mutational Profile of Multiple Lung Cancers in Xuanwei by Next-Generation Sequencing
00:00 - 00:00 | Presenter: Gang Guo
- Abstract
Loading... -
+
P89.12 - Real World Outcomes in EGFR-Mutant Relapsed and De Novo Stage IV Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Presenter: Amanda Jane Williams Gibson
- Abstract
Loading... -
+
P89.13 - Real-World Experience of NGS-Based Molecular Profiling in ‘Triple-Negative’ (EGFR/ALK/ROS1) Advanced NSCLC: Should we keep Testing Smokers?
00:00 - 00:00 | Presenter: Francesca Simionato
- Abstract
Loading... -
+
P89.14 - Preliminary Study on CTCs and CTECs in Non-Small Cell Lung Cancer Received Chemotherapy Combined with Anti-Angiogenic Therapy
00:00 - 00:00 | Presenter: LINA Zhang
- Abstract
Loading... -
+
P89.15 - Multiple Driver Oncogenes from Plasma of NSCLC Patients
00:00 - 00:00 | Presenter: Sita Andarini
- Abstract
Loading... -
+
P89.18 - Comprehensive Molecular Characterization of Chinese Patients with Oesophageal Cancer Related with Age
00:00 - 00:00 | Presenter: Lianke Liu
- Abstract
Loading...
-
+
P90 - Targeted Therapy - Clinically Focused - Misc. Topics
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Targeted Therapy - Clinically Focused
-
+
P90.01 - Clinical Characteristics and Outcome of Patients with Non-Small Cell Lung Cancer Harboring BRAF Mutations
00:00 - 00:00 | Presenter: mina Zhang
- Abstract
Loading... -
+
P90.02 - BRAF Mutation And Peridiagnosis Thromboembolic Events In Advanced NSCLC Patients
00:00 - 00:00 | Presenter: Inmaculada Aparicio Salcedo
- Abstract
Loading... -
+
P90.03 - A Phase 2 Trial of MRTX849 in Combination with Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
00:00 - 00:00 | Presenter: Alex I. Spira
- Abstract
Loading... -
+
P90.04 - RAS Precision Medicine Trans-Atlantic Partnership: Multi-Centre Pooled Analysis of RAS Pathway Mutations in Advanced NSCLC
00:00 - 00:00 | Presenter: Helen Adderley
- Abstract
Loading...
-
+
P92 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Misc. Topics
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
-
+
P92.01 - Genetic Landscape and Potential Therapy Regimen of Thymic Tumor
00:00 - 00:00 | Presenter: Naixin Liang
- Abstract
Loading...
-
+
P94 - Pathology, Molecular Pathology and Diagnostic Biomarkers - Misc. Topics
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
-
+
P94.01 - Comparison of Driver Mutations in Primary and Metastatic Lung Cancer
00:00 - 00:00 | Presenter: Xin Hong
- Abstract
Loading...
-
+
PL02 - Innovation to Bridge Lung Cancer Care Tomorrow (Japanese, Mandarin, Spanish Translation Available)
- 07:00 - 09:00
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
-
+
PL02.01 - Chair
07:00 - 07:00 | Presenter: Clarissa Mathias
- Abstract
No abstract available for this presentation
-
+
PL02.02 - Chair
07:00 - 07:00 | Presenter: James Chih-Hsin Yang
- Abstract
No abstract available for this presentation
-
+
PL02.03 - Human Data Science and the Omics Revolution: What Does It Mean for Oncology Patients?
07:00 - 07:20 | Presenter: Patrick Tan
- Abstract
No abstract available for this presentation
-
+
PL02.05 - Challenges in Clinical Application of Precision Medicine: From Targeted Therapies to Immunotherapy: Advanced Non-Small Cell Lung Cancer (NSCLC) as a Model
07:20 - 07:40 | Presenter: David R. Gandara
- Abstract
Loading... -
+
PL02.06 - Patient-Directed Innovation, Research and Clinical Trials
07:40 - 08:00 | Presenter: Lisa C Goldman
- Abstract
Loading... -
+
PL02.07 - Translational Medicine: An Engine of Change for Bringing New Technology to the Community
08:00 - 08:20 | Presenter: Michael Boyer
- Abstract
Loading... -
+
PL02.08 - Live Q&A
08:20 - 09:00
- Abstract
No abstract available for this presentation
-
+
ES01 - Choosing Systemic Therapies After Chemoimmunotherapy in NSCLC
- 09:15 - 10:15
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Antibody Drug Conjugates, Novel Therapeutics and Cytotoxics
-
+
ES01.01 - Non-Squamous
09:15 - 09:35 | Presenter: Virote Sriuranpong
- Abstract
No abstract available for this presentation
-
+
ES01.02 - Choosing Systemic Therapies After Chemoimmunotherapy – Squamous
09:35 - 09:55 | Presenter: Claudio Marcelo Martin
- Abstract
Loading... -
+
ES01.03 - Systemic Therapy after Chemo IO in Small Cell Lung Cancer
09:55 - 10:15 | Presenter: Charu Aggarwal
- Abstract
No abstract available for this presentation
-
+
OA01 - Established Drugs in Special Populations and New Drugs in Established Populations
- 09:15 - 10:15
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Immunotherapy (Phase II/III Trials)
-
+
OA01.01 - Chair
09:15 - 09:15 | Presenter: Noemi Reguart
- Abstract
No abstract available for this presentation
-
+
OA01.02 - Chair
09:15 - 09:15 | Presenter: Jiuwei Cui
- Abstract
No abstract available for this presentation
-
+
OA01.03 - Clinical Benefits of First-Line (1L) Cemiplimab Monotherapy by PD-L1 Expression Levels in Patients With Advanced NSCLC
09:15 - 09:25 | Presenter: Saadettin Kilickap
- Abstract
Loading... -
+
OA01.04 - Tumor Mutation Burden (TMB) by Next Generation Sequencing (NGS) Associates with Survival (OS) in Lung-MAP Immunotherapy Trials S1400I and S1400A
09:25 - 09:35 | Presenter: Fred R Hirsch
- Abstract
Loading... -
+
OA01.05 - Discussant
09:35 - 09:40 | Presenter: Edward B. Garon
- Abstract
No abstract available for this presentation
-
+
OA01.06 - Randomised Phase 2 Study of Nivolumab (N) Versus Nivolumab and Ipilimumab (NI) Combination in EGFR Mutant NSCLC
09:40 - 09:50 | Presenter: Gillianne Geet Yi Lai
- Abstract
Loading... -
+
OA01.07 - A Phase II Study of the Oral Selective AXL Inhibitor Bemcentinib with Pembrolizumab in Patients with Advanced NSCLC
09:50 - 10:00 | Presenter: Matthew G. Krebs
- Abstract
Loading... -
+
OA01.08 - Discussant
10:00 - 10:05 | Presenter: Justin Gainor
- Abstract
No abstract available for this presentation
-
+
OA01.09 - Live Q&A
10:05 - 10:15
- Abstract
No abstract available for this presentation
-
+
OA02 - Updates in Locally Advanced NSCLC
- 09:15 - 10:15
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Locoregional and Oligometastatic Disease
-
+
OA02.01 - Chair
09:15 - 09:15 | Presenter: Kenichi Suda
- Abstract
No abstract available for this presentation
-
+
OA02.02 - Chair
09:15 - 09:15 | Presenter: Antoinette Wozniak
- Abstract
No abstract available for this presentation
-
+
OA02.03 - Pembrolizumab Plus Platinum Chemotherapy and Radiotherapy in Unresectable, Locally Advanced, Stage III NSCLC: KEYNOTE-799
09:15 - 09:25 | Presenter: Martin Reck
- Abstract
Loading... -
+
OA02.04 - Randomized Phase Ⅱ Trial (RTOG1106) on Midtreatment PET/CT Guided Adaptive Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer
09:25 - 09:35 | Presenter: Feng-Ming (Spring) Kong
- Abstract
Loading... -
+
OA02.05 - Local, Regional and Pulmonary Failures in the Randomised PET-Boost Trial for NSCLC Patients
09:35 - 09:45 | Presenter: Saskia Anne Cooke
- Abstract
Loading... -
+
OA02.06 - PSM Analysis Results from REFRACT: A Multi-Center Cohort Study Investigating the Treatment Patterns in EGFR-Mutant Unresectable LA- NSCLC
09:45 - 09:55 | Presenter: Nan Bi
- Abstract
Loading... -
+
OA02.07 - Discussant
09:55 - 10:05 | Presenter: You Lu
- Abstract
No abstract available for this presentation
-
+
OA02.08 - Live Q&A
10:05 - 10:15
- Abstract
No abstract available for this presentation
-
+
ES02 - Pro-Con: Do We Need Biomarkers to Guide the Choice of Immunotherapy Treatment?
- 10:30 - 11:30
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Immunotherapy (Phase II/III Trials)
-
+
ES02.01 - We Should Choose Treatment Based on PD-L1, TMB and Other Biomarkers
10:30 - 10:45 | Presenter: Ticiana A Leal
- Abstract
No abstract available for this presentation
-
+
ES02.02 - Immune Checkpoint Blockade for All NSCLC Regardless of PD-L1, TMB or Other Biomarkers
10:45 - 11:00 | Presenter: Naiyer Rizvi
- Abstract
No abstract available for this presentation
-
+
ES02.03 - We Should Use IO Alone as Maintenance
11:00 - 11:15 | Presenter: Roy S. Herbst
- Abstract
No abstract available for this presentation
-
+
ES02.04 - We Should Use Combination of IO and Chemotherapy as Maintenance
11:15 - 11:30 | Presenter: Marina Chiara Garassino
- Abstract
No abstract available for this presentation
-
+
ES03 - Understanding and Treating Oligometastatic Diseases
- 10:30 - 11:30
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Locoregional and Oligometastatic Disease
-
+
ES03.01 - Chair
10:30 - 10:30 | Presenter: Linda W Martin
- Abstract
No abstract available for this presentation
-
+
ES03.02 - Chair
10:30 - 10:30 | Presenter: Yasushi Nagata
- Abstract
No abstract available for this presentation
-
+
ES03.03 - Characterization and Classification of Oligometastatic Disease
10:30 - 10:42 | Presenter: Matthias Guckenberger
- Abstract
No abstract available for this presentation
-
+
ES03.04 - Timing of Systemic Therapy in OMD
10:42 - 10:54 | Presenter: Simon Ekman
- Abstract
Loading... -
+
ES03.05 - Surgery as a Component of Local Consolidative Therapy
10:54 - 11:06 | Presenter: Mara B Antonoff
- Abstract
Loading... -
+
ES03.06 - Radiation as a Component of Treatment for Oligometastatic Disease
11:06 - 11:18 | Presenter: Kevin Lee Min Chua
- Abstract
No abstract available for this presentation
-
+
ES03.07 - Live Q&A
11:18 - 11:30
- Abstract
No abstract available for this presentation
first
prev
